CRISIL Limited (NSE:CRISIL)
India · Delayed Price · Currency is INR 4,294.00
-35.80 (-0.83%)
Mar 6, 2026, 3:29 PM IST
CRISIL Revenue
In the year 2025, CRISIL had annual revenue of 36.49B INR with 11.94% growth. CRISIL had revenue of 10.82B in the quarter ending December 31, 2025, with 18.47% growth.
Revenue
36.49B
Revenue Growth
+11.94%
P/S Ratio
8.60
Revenue / Employee
7.82M
Employees
4,666
Market Cap
313.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.49B | 3.89B | 11.94% |
| Dec 31, 2024 | 32.60B | 1.20B | 3.83% |
| Dec 31, 2023 | 31.40B | 3.71B | 13.39% |
| Dec 31, 2022 | 27.69B | 4.68B | 20.34% |
| Dec 31, 2021 | 23.01B | 3.19B | 16.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| State Bank of India | 3.70T |
| HDFC Bank | 2.85T |
| ICICI Bank | 1.92T |
| Bajaj Finance | 412.83B |
| Cholamandalam Financial Holdings | 203.84B |
| Central Bank of India | 171.39B |
| UCO Bank | 120.32B |
| Go Digit General Insurance | 98.90B |
CRISIL News
- 3 months ago - Crisil features in Chartis RiskTech100 2026 for third successive year - Business Upturn
- 5 months ago - CRISIL shares jump over 2% after announcing $38 million acquisition of McKinsey’s PriceMetrix - Business Upturn
- 8 months ago - CRISIL board declares second interim dividend of Rs 9 per share - Business Upturn
- 8 months ago - Crisil Q1 Results: Revenue up 5.7% YoY to Rs 843 crore, Net Profit up 14% YoY - Business Upturn
- 11 months ago - CRISIL Q4 FY25 Results: Net profit rises 16% YoY to ₹159.8 crore, Margin expands to 28.5% - Business Upturn
- 1 year ago - Crisil shares drop over 8% as Q3 revenue declines - Business Upturn
- 1 year ago - Crisil Q3 Results: Revenue down 0.5% to Rs 912.91 crore, Net Profit up 7.03% YoY - Business Upturn
- 1 year ago - Top gainers today: Piramal Pharma surges 5.85%, CRISIL rises 3.63%, Aditya Birla Capital gains 2.76%, AstraZeneca Pharma up 2.57% - Business Upturn